Latest diabetes mellitus Stories

LOS ANGELES, Feb. 1, 2013 /PRNewswire/ -- Renowned bariatric surgeon, Michael Feiz, M.D., F.A.C.S., has some thoughts on fighting the seemingly unstoppable spread of type 2 diabetes; it all comes down to reducing the body's production of a particular hormone through such procedures as gastric sleeve surgery. The ghrelin hormone appears to be responsible for sending hunger messages to the brain and may be the primary reason many of us often feel hungry even after we've eaten more...

New research has shown the presence of a disease affecting small blood vessels, known as microangiopathy, in the bone marrow of diabetic patients. While it is well known that microangiopathy is the cause of renal damage, blindness and heart attacks in patients with diabetes, this is the first time that a reduction of the smallest blood vessels has been shown in bone marrow, the tissue contained inside the bones and the main source of stem cells. These precious cells not only replace old...

SAN DIEGO, Feb. 1, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today that it has acquired ownership from Smiths Medical ASD, Inc. of over 23 U.S. patents and patent applications relating to the treatment of diabetes. As part of this transaction, Tandem has also obtained a license to 28 other U.S. patents and patent applications owned by Smiths Medical. This license affords Tandem exclusive access to technologies useful for future product development in the...

April Flowers for redOrbit.com - Your Universe Online Researchers from the Metabolism Institute at Mount Sinai Hospital’s Icahn School of Medicine led a new animal study showing that binge drinking causes insulin resistance which, in turn, increases the risk of type 2 diabetes. The study, published in the journal Science Translational Medicine, also discovered that alcohol disrupts insulin-receptor signaling by causing inflammation in the hypothalamus. "Insulin resistance has emerged...

FirstVitals Health and Wellness Inc., of California, a technology-enabled service company focused on reducing complications of diabetes related to neuropathy and foot ulcers/amputation, announced that it has received a donation from NeuroMetrix, Inc. (Nasdaq:NURO) to supplement its Centers for Medicare and Medicaid Innovation (CMMI) Grant project in Hawaii. Honolulu, HI (PRWEB) January 29, 2013 NeuroMetrix, a medical device company focused on the diagnosis and treatment of the...

PORTLAND, Ore., Jan. 28, 2013 /PRNewswire/ -- For people with diabetes, meeting the recommended guidelines for blood pressure and cholesterol is even more important than meeting the guidelines for blood-sugar control in reducing the risk of heart attack or stroke, according to a new Kaiser Permanente study published today in the Journal of General Internal Medicine. The study included more than 26,000 patients with diabetes. Patients who met guidelines for all three risk...

NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- Pamlab L.L.C., developer and marketer of Metanx(®), announced today that a multicenter study, done in collaboration with Tulane University, was published in The American Journal of Medicine. The study suggests that nutritional management of diabetic peripheral neuropathy (DPN) with L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate, a prescription medical food dispensed by prescription and commercially known as Metanx(®),...

For 10+ years Extend Nutrition™ has been a leading nutritional snack Company with the only product line, developed by a world-renowned doctor, clinically proven to reduce the calories consumed at the next meal by an average of 21%. Saint Louis, MO (PRWEB) January 24, 2013 Trying a new weight loss plan can feel overwhelming. There is a plethora of contradictory health and nutrition information available – making it nearly impossible to make healthy decisions. Extend Nutrition takes the...

KALAMAZOO, Mich., Jan. 24, 2013 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data from a Phase 2b study of the company's prototype insulin sensitizer in patients diagnosed with type 2 diabetes. The data demonstrate MSDC-0160, a novel once-a-day oral insulin sensitizer and the first in a new class of therapeutic agents called mTOT Modulators(TM), met the study's primary endpoint of significantly reducing fasting plasma glucose...

OTTAWA, Jan. 24, 2013 /CNW/ - Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients already at risk for the disease. Based on the review of all available data, Health Canada concluded that the risk of diabetes appears to be mainly in patients with pre-existing risk factors for diabetes, such as high levels of...